https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18846 Wed 11 Apr 2018 15:20:13 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22910 Suncus murinus revealed that it had "broad-spectrum" anti-emetic effects against stimuli acting via both central (vestibular system, area postrema) and peripheral (abdominal vagal afferents) inputs. One of several hypotheses discussed here is that the anti-emetic effect is due to acute depletion of substance P (or another peptide) at a critical site (e.g. nucleus tractus solitarius) in the central emetic pathway. Studies in Suncus murinus revealed a potential for a long lasting (one month) effect against the chemotherapeutic agent cisplatin. Subsequent studies using telemetry in the conscious ferret compared the anti-emetic, hypothermic and hypertensive effects of resiniferatoxin (pungent) and olvanil (non-pungent) and showed that the anti-emetic effect was present (but reduced) with olvanil which although inducing hypothermia it did not have the marked hypertensive effects of resiniferatoxin. The review concludes by discussing general insights into emetic pathways and their pharmacology revealed by these relatively overlooked studies with TRPV1 activators (pungent an non-pungent; high and low lipophilicity) and antagonists and the potential clinical utility of agents targeted at the TRPV1 system.]]> Wed 11 Apr 2018 13:53:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22909 Wed 11 Apr 2018 11:01:15 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34245 Tue 03 Sep 2019 18:27:31 AEST ]]>